Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

CHOUSSAT

Showing results (191-200 of 216) with videos related to

Pageof 22
Sort By:
Circulation|May 23, 2001
Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary interventionJ P Collet, G Montalescot, C Lesty, et al.
Archives of Cardiovascular Diseases|July 26, 2008
Characteristics and prognosis of patients with angiographic stent thrombosis: comparison between drug-eluting and bare-metal stentsC Le Feuvre, G Helft, S Cohen, et al.
Journal of the American College of Cardiology|February 7, 2003
Enoxaparin in unstable angina patients who would have been excluded from randomized pivotal trialsJean Philippe Collet, Gilles Montalescot, Erika Fine, et al.
Archives of Cardiovascular Diseases|September 24, 2008
Feasibility of outpatient coronary angiography with "ad hoc" angioplastyArnaud Chaumeil, Farzin Beygui, Jean-Philippe Collet, et al.
Journal of the American College of Cardiology|January 23, 2004
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) studyMiles Dalby, Gilles Montalescot, Claire Bal dit Sollier, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1984
[Cardiac stimulation in children. A multicenter study of 241 patients]A Vanetti, D Gaillard, P A Chaptal, et al.
Archives of Cardiovascular Diseases|May 5, 2015
Sex-related differences after contemporary primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionOlivier Barthélémy, Philippe Degrell, Emmanuel Berman, et al.
Archives of Cardiovascular Diseases|July 18, 2015
Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary interventionGoran Loncar, Olivier Barthelemy, Emmanuel Berman, et al.
Circulation|October 13, 2004
Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromesJ P Collet, G Montalescot, B Blanchet, et al.
The American Journal of Cardiology|August 18, 2000
Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarctionR Choussat, G Montalescot, J Collet, et al.
Pageof 22

Showing results (191-200 of 216) with videos related to

Sort By:
Pageof 22
Circulation|May 23, 2001
Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary interventionJ P Collet, G Montalescot, C Lesty, et al.
Archives of Cardiovascular Diseases|July 26, 2008
Characteristics and prognosis of patients with angiographic stent thrombosis: comparison between drug-eluting and bare-metal stentsC Le Feuvre, G Helft, S Cohen, et al.
Journal of the American College of Cardiology|February 7, 2003
Enoxaparin in unstable angina patients who would have been excluded from randomized pivotal trialsJean Philippe Collet, Gilles Montalescot, Erika Fine, et al.
Archives of Cardiovascular Diseases|September 24, 2008
Feasibility of outpatient coronary angiography with "ad hoc" angioplastyArnaud Chaumeil, Farzin Beygui, Jean-Philippe Collet, et al.
Journal of the American College of Cardiology|January 23, 2004
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) studyMiles Dalby, Gilles Montalescot, Claire Bal dit Sollier, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1984
[Cardiac stimulation in children. A multicenter study of 241 patients]A Vanetti, D Gaillard, P A Chaptal, et al.
Archives of Cardiovascular Diseases|May 5, 2015
Sex-related differences after contemporary primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionOlivier Barthélémy, Philippe Degrell, Emmanuel Berman, et al.
Archives of Cardiovascular Diseases|July 18, 2015
Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary interventionGoran Loncar, Olivier Barthelemy, Emmanuel Berman, et al.
Circulation|October 13, 2004
Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromesJ P Collet, G Montalescot, B Blanchet, et al.
The American Journal of Cardiology|August 18, 2000
Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarctionR Choussat, G Montalescot, J Collet, et al.
Pageof 22